QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

SANUWAVE Health (OTC:SNWV) reported quarterly earnings of $0.46 per share which beat the analyst consensus estimate of $0.32 by...

Core News & Articles

Reimbursement for the 97610 code for UltraMIST products remains materially unchanged for 2026 with payment for treatment provid...

 stock-market-today-dow-jones-nasdaq-100-sp-500-futures-turn-greentrilogy-metals-amd-applovin-in-focus-updated

Editor’s Note: The future prices of benchmark tracking ETFs and lede were updated in the story.) US futures trimmed earlier ...

 mccormick-telomir-pharmaceuticals-and-3-stocks-to-watch-heading-into-tuesday

U.S. stock futures mixed, key stocks to watch: MKC, SNWV, PENG, TELO, SAR. Check out premarket coverage. Cramer warns on chip s...

Core News & Articles

Northland Capital Markets analyst Carl Byrnes initiates coverage on SANUWAVE Health (NASDAQ:SNWV) with a Outperform rating a...

Core News & Articles

Roth Capital analyst Kyle Bauser maintains SANUWAVE Health (NASDAQ:SNWV) with a Buy and raises the price target from $54 to ...

Core News & Articles

Financial OutlookThe Company forecasts Q3 2025 revenue of $12-$12.7 million and reiterates full year 2025 revenue guidance of $...

Core News & Articles

SANUWAVE Health (OTC:SNWV) reported quarterly earnings of $0.01 per share which beat the analyst consensus estimate of $(0.09) ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION